Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Weaning of immunosuppression in living donor liver transplant recipients.

Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T, Fujita S, Hayashi M, Kanematsu T, Tanaka K.

Transplantation. 2001 Aug 15;72(3):449-54.

PMID:
11502975
2.

Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance.

Takatsuki M, Uemoto S, Inomata Y, Sakamoto S, Hayashi M, Ueda M, Kanematsu T, Tanaka K.

Transpl Immunol. 2001 Feb;8(4):279-86.

PMID:
11316071
3.

Role of HLA compatibility in pediatric living-related liver transplantation.

Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, Oike F, Kaihara S, Egawa H, Tanaka K.

Transplantation. 2002 Oct 27;74(8):1175-80.

PMID:
12438966
4.

[Weaning of immunosuppression in living-related liver transplantation].

Inomata Y, Takatsuki M, Uemoto S, Tanaka K.

Nihon Rinsho Meneki Gakkai Kaishi. 1999 Dec;22(6):431-5. Japanese.

PMID:
10726480
5.

Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea.

Lee JH, Lee SK, Lee HJ, Seo JM, Joh JW, Kim SJ, Kwon CH, Choe YH.

Yonsei Med J. 2009 Dec 31;50(6):784-8. doi: 10.3349/ymj.2009.50.6.784. Epub 2009 Dec 18.

6.

Annual trends and triple therapy--1991-2000.

Nishikawa K, Terasaki PI.

Clin Transpl. 2001:247-69.

PMID:
12211788
7.

Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience.

Toyoki Y, Hakamada K, Narumi S, Totsuka E, Nara M, Ono H, Ishizawa Y, Sasaki M.

Transplant Proc. 2004 Oct;36(8):2279-81.

PMID:
15561218
8.

The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.

Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.

Transplantation. 2003 Apr 15;75(7):1020-5.

PMID:
12698091
9.

Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.

Fuchinoue S, Sawada T, Tsuji K, Kai K, Tojimbara T, Nakajima I, Shiraga H, Ito K, Teraoka S.

Transplantation. 2002 Mar 27;73(6):948-52.

PMID:
11923698
10.

Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.

Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.

Liver Transpl. 2005 Nov;11(11):1395-402.

11.

What is the best immunosuppression in living donor liver transplantation?

Ringe B, Moritz M, Zeldin G, Soriano H.

Transplant Proc. 2005 Jun;37(5):2169-71.

PMID:
15964369
12.

Evolutionary experience with immunosuppression in pediatric intestinal transplantation.

Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J.

J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80.

PMID:
15868597
13.

Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.

Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.

Transpl Int. 2001 Dec;14(6):420-8.

14.

Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.

Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.

Liver Transpl. 2003 Jun;9(6):587-95.

15.

Buccal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation.

Goorhuis JF, Scheenstra R, Peeters PM, Albers MJ.

Pediatr Transplant. 2006 Feb;10(1):74-7.

PMID:
16499591
16.

Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.

Sato Y, Ichida T, Watanabe H, Yamamoto S, Oya H, Nakatsuka H, Kobayashi T, Watanabe T, Kameyama H, Hatakeyama K.

Hepatogastroenterology. 2003 May-Jun;50(51):601-6.

PMID:
12828042
17.

Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning?

Lauro A, Diago Usò T, Masetti M, Di Benedetto F, Cautero N, De Ruvo N, Dazzi A, Quintini C, Begliomini B, Siniscalchi A, Ramacciato G, Risaliti A, Miller CM, Pinna AD.

Transplant Proc. 2005 Jun;37(5):2214-20.

PMID:
15964382
18.

Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.

Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT.

Liver Transpl. 2002 Mar;8(3):212-8.

19.

Long-term use of FK 506 in living related liver transplantation.

Uemoto S, Tanaka K, Tokunaga Y, Nishizawa T, Sawada H, Katoh H, Yamamoto E, Yamaoka Y, Ozawa K.

Transpl Int. 1994;7 Suppl 1:S81-4.

PMID:
11271341
20.

Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation.

Jain A, Mazariegos G, Kashyap R, Marsh W, Khanna A, Iurlano K, Fung J, Reyes J.

Pediatr Transplant. 2001 Apr;5(2):93-8.

PMID:
11328546

Supplemental Content

Support Center